baber/WOPTO huggingface dataset:
Patent NZ-264480-A (NZ)
Title: Aryl cyclohexane(thio)carboxamide derivatives, preparation and medicaments thereof
Inventor: KABASAWA YASUHIRO
IPC: C07C13/18
Filed: 1994-09-19
Abstract: To provide a novel cyclohexane derivative, a cyclohexane derivative is defined by the formula (I) or a pharmacologically acceptable salt thereof: <CHEM> (wherein R<1> and R<2> may be the same or different from each other and each represents hydrogen or lower alkyl; R<3> represents optionally substituted aryl or optionally substituted heteroaryl; X represents oxygen or sulfur; and Y represents a group represented by the formula: <CHEM> or the like). The compound of the present invention is useful as a preventive and therapeutic agent for diseases against which a potassium channel opening action is efficacious.
Patent NZ-271704-A (NZ)
Title: Contrast agent comprising gas bubbles encapsulated by non-polymerisable block or graft copolymer surfactant; polymer surfactants
Inventor: DUGSTAD HARALD
IPC: C09K23/00
Filed: 1994-09-05
Abstract: PCT No. PCT/GB94/01923 Sec. 371 Date Mar. 14, 1997 Sec. 102(e) Date Mar. 14, 1997 PCT Filed Sep. 5, 1994 PCT Pub. No. WO95/06518 PCT Pub. Date Mar. 9, 1995The present invention relates to polymer-based gas-containing contrast agents in which microbubbles of gas are encapsulated by non-polymerizable wall-forming block or graft copolymer surfactants. The polymer surfactants are preferably biodegradable and include block and graft copolymers containing linkages of formula (I):-(O)m-CO-O-C(R1R2)-O-CO-(O)n-(I)where R1 and R2 each represent a hydrogen atom or a carbon-attached monovalent organic group, or R1 and R2 together form a carbon-attached divalent organic group and m and n are each zero or 1.
Patent NZ-331220-A (NZ)
Title: Gene expression comprising manipulation of a GAL4 DNA-binding domain to produce an A/T content of 45% or less
Inventor: HASELOFF JAMES PHILLIP
IPC: A01H5/00
Filed: 1997-02-14
Abstract: The present invention relates to a nucleic acid sequence, expressible in a plant cell, encoding at least an effective portion of a GAL4 DNA binding domain, the sequence having a % A/T base content substantially reduced relative to the wild-type yeast sequence, characterised in that the % A/T base content is less than 45%. Further claimed is a construct comprising the above sequence, and a method of expressing a gene of interest in a known pattern in a plant or part thereof.
Patent NZ-336291-A (NZ)
Title: Pulp forming machine with mould carrying and locking details
Inventor: SMIT BENNO FRANK
IPC: D21J5/00
Filed: 1999-06-15
Abstract: A pulp forming machine includes a forming head including a platen and plurality of mould carriers. The mould carriers are connected to the platen by mould carrier support means which allow the mould carrier and the platen to transmit forces perpendicular to the general plane of the platen but allow movement and expansion of each mould carrier in the general plane of the platen. Mould carrier to mould carrier locating means locate the mould carriers of opposing platens during the forming process to align moulds carried on the mould carriers with cooperating moulds of the cooperating platen.
Patent NZ-336445-A (NZ)
Title: Heptapeptide oxytocin analogues
Inventor: MELIN PER
IPC: A61K38/095
Filed: 1997-11-21
Abstract: Heptapeptide analogues or pharmaceutically acceptable salts thereof, with oxytocin antagonist activity, consist of a hexapeptide moiety S and a C-terminal 'beta'-aminoalcohol residue Z bound to the moiety S by an amide bond, wherein the 'beta'-aminoalcohol Z is -NR-CH(Q)-CH2OH, Q is (CH2)n-NH-A, n is 1-6 and A is H or -C(=NH)NH2, and R is CH3 or C2H5. The moiety S is Mpa-X-Ile-Y-Asn-Abu wherein Mpa is 3-mercaptopropionis acid, X is a D-aromatic alpha-amino acid, Y is an aliphatic alpha-amino acid and Abu is alpha-aminobutyric acid.  The peptides are useful in the control of uterine contractions.
Patent NZ-502554-A (NZ)
Title: Sending information in one form to a service provider who converts it to another form to send to the recipient
Inventor: LINSTROM JEFFERSON HAL
IPC: H04L29/00
Filed: 2000-01-28
Abstract: A method of transmitting information between information senders 1a, 1b, 1c and intended recipients 2a, 2b, 2c.  To facilitate the delivery of the information from the sender 1 to the recipient 2, the sender 1 transmits the information to the service provider 3 which converts the information from a first storage medium to a second storage medium.  The service provider 3 then converts the information to a medium which will allow the intended recipient 2 to receive the message and determines the location of the intended recipient using a global position satellite locator which is associated with the recipient.  Reviewing the instructions of the sender 1 or reviewing the contact information of the intended recipient 2 determines the appropriate medium.  The information is then sent to the intended recipient 2.
Patent NZ-502740-A (NZ)
Title: Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
Inventor: ALBRECHT JANICE K
IPC: A61K38/12
Filed: 1998-09-16
Abstract: Ribavirin and/or alpha interferon are used in the manufacture of a pharmaceutical composition for treating a patient having chronic hepatitis C infection to eradicate detectable HCV-RNA by a method comprising administrating an effective amount of ribavirin and/alpha interferon in association with an effective amount of interferon alpha and/or ribavirin for a time period of 40-50 weeks. The patient is one having failed to response to a previous course of interferon alpha therapy and has a viral load of greater than 2 million copies per ml of serum as measured by HCV-RNA quantitative PCR of a HCV genotype type 1 infection.
Patent NZ-507171-A (NZ)
Title: Specific CD3 and CD7 antibodies in a mixture with a toxic moiety (e.g. Ricin A) for suppressing or eliminating over-reactive or malignant T cells and/or NK cells
Inventor: VAN OOSTERHOUT YPKE VINCENTIUS
IPC: A61K39/395
Filed: 1999-03-19
Abstract: A method of treating GvHD (graft-versus host disease) using molecules specifically recognising receptors on cells to be eliminated. In one preferred embodiment, an immunotoxin (IT) is a conjugate for instance, monoclonal antibody (MoAb), usually developed in a mouse, coupled to a potent toxin such as the A-chain of the potent plant toxin ricin (RTA). The MoAb-moiety first binds specifically to an antigen expressed on those cells which are to be eliminated where after the entire antigen-IT complex is internalized. The composition contains a mixture of a first molecule specifically recognising CD3 and a second molecule specifically recognising CD7, whereby at least one of the specifically recognising molecules are provided with a toxic moiety.
Patent NZ-509647-A (NZ)
Title: Farnesyl protein transferase inhibitors for treating arthropathies
Inventor: END DAVID WILLIAM
IPC: A61K31/4709
Filed: 1999-06-30
Abstract: A farnesyl protein transferase inhibitor of a compound of formula (I), or a compound of formula (II) or (III) which is metabolized in vivo to a compound of formula (I) is used in the manufacture of a medicament for treating arthropathies. The farnesyl protein transferase inhibitor can be in the form of a stereoisomeric form thereof, a pharmaceutically acceptable acid or base addition salt thereof. In formula (I), (II) and (III): the dotted line represents an optional bond; X is oxygen or sulphur; R1 is hydrogen, alkyl, Ar1, Ar2-alkyl, quinolinylalkyl, pyridylalkyl, hydroxyalkyl, alkyloxyalkyl, mono- or di- alkyl aminoalkyl, aminoalkyl, or -Alk1-C(=O)-R9, -Alk1-S(O)- R9 or -Alk1-S(O)2-R9; Alk1 is alkanediyl; R2, R3 and R16 are independently hydrogen, hydroxy, halo, cyano, alkyl, alkyloxy, hydroxyalkyloxy, alkyloxyalkyloxy, aminoalkyloxy, mono- or di-alkyl aminoalkyloxy, Ar1, Ar2- alkyl, Ar2-oxy, Ar2-alkyloxy, hydroxycarbonyl, alkyloxycarbonyl, trihalomethyl, trihalomethoxy, alkenyl, 4,4-dimethyloxazolyl; or when on adjacent positions R2 and R3 taken together may form a bivalent radical of formula -O- CH2-O-, -O-CH2-CH2-O-, -O-CH=CH-, -O-CH2-CH2-, -O-CH2-CH2- CH2-, or -CH=CH-CH=CH-; R4 and R5 independently are hydrogen, halo, Ar1, alkyl, hydroxyalkyl, alkyloxyalkyl, alkyloxy, alkylthio, amino, hydroxycarbonyl, alkyloxycarbonyl, alkyl-S(O)-alkyl or alkyl-S(O)2-alkyl; R6 and R7 independently are hydrogen, halo, cyano, alkyl, alkyloxy, Ar2-oxy, trihalomethyl, alkylthio, di-alkyl amino, or when on adjacent positions R6 and R7 taken together may form a bivalent radical of formula -O-CH2-O- or -CH=CH-CH=CH-; R8 is hydrogen, alkyl, cyano, hydroxycarbonyl, alkyloxycarbonyl, alkylcarbonylalkyl, cyanoalkyl, alkyloxycarbonylalkyl, carboxyalkyl, hydroxyalkyl, aminoalkyl, mono- or di-alkyl-aminoalkyl, imidazolyl, haloalkyl, alkyloxy-alkyl, aminocarbonylalkyl or -O-R10, -S- R10, -N-11R12, R9 to R12 are as defined in the specification; R17 is hydrogen, halo, cyano, alkyl, alkyloxycarbonyl or Ar1; R18 is hydrogen, alkyl, alkyloxy or halo; R19 is hydrogen or alkyl and Ar1 and Ar2 are independently optionally substituted phenyl.
Patent NZ-510952-A (NZ)
Title: Impregnation process for preparing a catalyst precursor and the catalyst
Inventor: VAN BERGE PETER JACOBUS
IPC: B01J37/02
Filed: 1999-10-04
Abstract: A process for preparing a catalyst precursor is disclosed, which comprises subjecting, in an initial treatment stage, a slurry of a catalyst support, an active catalyst component precursor, and water, to treatment at elevated temperature of from 60 to 95°C and at sub-atmospheric pressure, to impregnate the support with the precursor and to dry the impregnated support partially.  The initial treatment stage does not continue beyond a point where the impregnated carrier has a loss on ignition (LOI) which is less than 1.2 times its loss on ignition at incipient wetness LOIiw.  In a subsequent treatment stage, the partially dried impregnated support is subjected to more vigorous drying at elevated temperature of from 60 to 95°C and at sub-atmospheric pressure such that the temperature in the subsequent treatment stage exceeds that in the initial treatment stage and/or the sub-atmospheric pressure in the subsequent treatment stage is lower than in the initial stage, thereby to obtain a vigorous drying of the impregnated carrier in the subsequent treatment stage than in the initial treatment stage, with a dried impregnated carrier or support thereby being produced, and which is calcined to obtain the catalyst precursor. The catalyst precursor is reduced, to obtain a catalyst.
Patent NZ-517244-A (NZ)
Title: Main beam connection
Inventor: LIN YU
IPC: E04B9/10
Filed: 2002-02-15
Abstract: A main beam connector capable of being assembled in the field with an identical main beam connector to form an end-to-end connection of main beams in a ceiling grid the main beam connector having: a) a pocket formed about an opening in a web of the main beam the pocket being formed from the web; and b) a clip secured to an end of the main beam within an assembled end-to-end connection of main beams  1) a forward end of the clip adapted to be clamped within a pocket formed from the web of the main beam in the identical connector, and  2) an edge in the clip adapted to engage an opening in the web of the main beam in the identical connector, when the forward end of the clip is clamped within the pocket formed about the opening, the pocket being formed from the web.
Patent NZ-522277-A (NZ)
Title: Virulence genes, proteins and their use intreating diseases associated with infection by Neisseria, including meningitis
Inventor: TANG CHRISTOPH
IPC: A61P31/04
Filed: 2001-05-08
Abstract: A series of genes from Neisseria meningitidis are shown to encode gene products that are implicated in virulence. The identification of these genes therefore allows attenuated microorganisms to be produced. Furthermore, the genes or their encoded products can be used in the manufacture of vaccines for therapeutic application, including veterinary treatment.
Patent NZ-522325-A (NZ)
Title: High cleaning dentifrice
Inventor: DURGA GARY A
IPC: A61K8/46
Filed: 2001-05-08
Abstract: A dentifrice composition is disclose, which comprises an orally acceptable vehicle containing from about 5 to about 30% by weight silica hydrogel particles, the particles containing about 10 to 35% by weight water having: (a) A mean particle size from about 5 to about 12 microns; (b) An Einlehner hardness of from 1 to about 20; (c) An oil absorption of from about 40 to less than about 11 cc/100g; (d) A BET surface area from 100 to 700 m2/g of silica; the morphology of the particles being characterized by glass conchoidal fracture surfaces whereby the dentifrice composition has a RDA of 110 to 200 and a PCR from about 150 to about 300.
Patent NZ-524900-A (NZ)
Title: An articulated concrete joint member
Inventor: MCLEAN PETER CHARLES
IPC: E01C11/02
Filed: 2001-09-28
Abstract: An articulated concrete joint member (1) including a resilient core (2), the core (2) having connections means (3) attached thereto, the connection means (3) adapted to link two co-planar concrete slabs (5, 6) along an adjacent peripheral edge of each slab, wherein on application of an out-of-plane displacement to one of the co-planar concrete slabs (5, 6) the displacement is transmitted to the other slab through pivoting about the articulated joint member (1). In one embodiment, the articulated concrete joint member (1), which further includes crack propagation means (4), is fully immersed in the concrete slab so that the slab is subjected to extraneous loads, the slab cracks along predetermined lines of weakness (7).
Patent NZ-528254-A (NZ)
Title: Combined neisserial compositions
Inventor: GIULIANI MARZIA MONICA
IPC: A61K38/16
Filed: 2000-05-19
Abstract: A composition is disclosed which comprises an isolated first protein and an isolated second protein. The first protein is depicted to comprise an amino acid sequence which has 70% or more sequence identity to SEQ ID NO:894, 896 and/or 898 and/or is a fragment of 10 or more amino acids of SEQ ID NO:894, 896 and/or 898. The second protein is described to comprise an amino acid sequence selected from even-numbered SEQ ID NOs:2-4002, and/or is a fragment of 10 or more amino acids of even-numbered SEQ ID NOs:2-4002. There is a proviso that SEQ ID NOs:2182, 2184 and/or 2186 are not selectable sequences nor compose a fragment of the second protein. The use of the first and second proteins is disclosed to be in the manufacture of a medicament for treating or preventing infection due to the Neisserial bacteria.
Patent NZ-529129-A (NZ)
Title: Anthranilamides, processes for the production thereof, their use as antiarrhythmics, and pharmaceutical preparations thereof
Inventor: BRENDEL JOACHIM
IPC: C07D405/12
Filed: 2002-04-13
Abstract: Anthranilic acid amides, a method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these anthranilic acid amides are disclosed. The anthranilic acid amides consist of compounds of formula (I) in which R(1) to (R7) have the meanings as cited in the claims, act upon the Kv1.5 potassium channel, and inhibit a potassium stream described as an "ultra-rapidly activating delayed rectifier" in the human cardiac atrium. The compounds are therefore especially suited as novel antiarrhythmic active substances, particularly for treating and preventing atrial arrhythmias, e.g. atrial fibrillation AF or atrial flutter.
Patent NZ-529561-A (NZ)
Title: Sail and method of manufacture thereof
Inventor: KISS AARON
IPC: B63H9/06
Filed: 2002-04-12
Abstract: A sailboat sail includes a sheet of material that contains stretchable webs that assume a planar orientation when placed against a planar surface, but which can stretch into a sail or airfoil orientation when mounted to a sailboat and exposed to wind loading. The sheet includes at least two webs of PVC vinyl laminated together between which is disposed a scrim of polyester yarn. The yarn is cross-hatched in a predetermined directional pattern. The sail has informational content, such as advertising, printed thereon or otherwise imparted thereto. A method for manufacturing such a sail includes providing a sheet of the aforementioned sail material, printing on one or both sides of the sheet information content to be displayed while the sail is mounted upon a sailboat, and cutting the sheet into the shape of a sail. The sheet may be cut before or after the information is imprinted thereon.
Patent NZ-535358-A (NZ)
Title: Base station synchronization for handover in a hybrid GSM/CDMA network
Inventor: GRILLI FRANCESCO
IPC: H04J3/00
Filed: 2001-01-08
Abstract: In a mobile wireless communications system, which includes a base station of a first type operating according to a first air interface, and base stations of a second type operating according to a second air interface, a method for handing over a mobile station in the system from a first base station, which is of a first type, to a second base station, which is of the second type, wherein one of the first and second air interfaces comprises a TDMA interface, and the other of the interfaces comprises a CDMA interface, this comprises: (a) Establishing a communication link over the first air interface between the mobile station and the first base station; (b) Receiving data from the mobile station responsive to a signal received by the mobile station over the second air interface from the second base station, substantially without breaking the communication link with the first base station. Wherein receiving the data comprises applying a weighting factor to the measurement of signal strength; and (c) Handing over the mobile station from the first to the second base station, which is of a second type, wherein one of the first and second air interfaces comprises a TDMA interface and the other of the interfaces a CDMA interface. (62) Divided out of 519677
Patent NZ-537897-A (NZ)
Title: Novel 2-arylthiazole compounds as PPARalpha and PPARgamma agonists
Inventor: BINGGELI ALFRED
IPC: C07D277/24
Filed: 2003-08-21
Abstract: 2-arylthiazole compounds of formula (I), pharmaceutically acceptable salts and esters thereof, that are suitable as PPARalpha and PPARgamma agonists are disclosed, wherein R1 to R10, X, Y and n are as defined in the specification. These compounds are suitable for use in the treatment of diseases such as diabetes.
Patent NZ-539834-A (NZ)
Title: Isoindoline derivatives
Inventor: TOYOOKA KOUHEI
IPC: C07D401/14
Filed: 2003-11-25
Abstract: Disclosed is a compound represented by formula (I) wherein: m is an integer of 2 and each R1 is the same or different and is selected from the group consisting of alkyl and alkoxy; or when R1 is two adjacent groups, the two R1 groups taken together may form a saturated or unsaturated 5- or 6- membered cyclic group which may have 1 or 2 hetero atoms selected from the group consisting of sulphur, nitrogen and oxygen; X is oxygen or sulphur; R2 is selected from the group consisting of phenyl, benzyl, pyridyl, pyridylmethyl, pyrimidinyl, cyclohexyl, methylpiperazinyl, indanyl and naphthyl, all of which may optionally be substituted, provided that when R2 is phenyl, the 3- and 4- positions of the phenyl moiety are not substituted by alkoxy groups at the same time; and the remainder of the substituents are as described in the specification. Compounds of the type disclosed are useful for inducing a sedative effect or anaesthesia in a mammal.
Patent NZ-541265-A (NZ)
Title: Hair braider configured to plait or braid strands of hair in response to a motor drive
Inventor: BOUSFIELD PATRICK
IPC: D04C7/00
Filed: 2004-01-16
Abstract: A hair braider (100) for a three--bundle plait or braid includes a body having a handle (120) and a head portion (110) at one end of the handle; a selectively actuatable drive source disposed within the body; and first and second rotatable rotors disposed within and accessible through openings formed in the head portion. They are operatively coupled to the drive source through a plurality of gears such that they rotate in opposite directions. The hair braider further includes a plurality of hair retaining members (200) that are received within openings formed through the first and second rotatable rotors, wherein each hair retaining member has a bore formed therethrough for receiving one bundle of hair. A mechanism transfers at a transfer location one hair retaining member from one rotor to the other rotor as the rotors rotate. The rotation of the rotors in opposite directions and he successive transfer of one hair retaining member from one rotor to the other rotor results in a true, three-bundle braid being formed.
Patent NZ-541753-A (NZ)
Title: Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
Inventor: MEISSONNIER JULIEN
IPC: A61K9/48
Filed: 2004-01-21
Abstract: Disclosed is a dispersion of crystals or granules of active substance in a lipophilic vehicle, wherein said lipophilic vehicle has a solubilizing power for the active substance of less than 1.5 times the active substance concentration for which a taste is detected in water, and wherein said crystals or granules are coated by a coating for taste masking.
Patent NZ-543801-A (NZ)
Title: Method and apparatus for identifying diagnostic components of a system
Inventor: KIIVERI HARRI
Filed: 2002-10-17
Abstract: Method and apparatus is described for identifying a subset of components of a system, the subset being capable of predicting a feature of a test sample. The method comprises generating a linear combination of components and component weights in which values for each component are determined from data generated from a plurality of training samples, each training sample having a known feature. A model is defined for the probability distribution of a feature wherein the model is conditional on the linear combination and wherein the model is not a combination of a binomial distribution for a two class response with a probit function linking the linear combination and the expectation of the response. A prior distribution is constructed for the component weights of the linear combination comprising a hyperprior having a high probability density close to zero, and the prior distribution and the model are combined to generate a posterior distribution. A subset of components is identified having component weights that maximise the posterior distribution.
Patent NZ-543891-A (NZ)
Title: Powdered drinks and process for producing the same
Inventor: INOUE TAKASHI
Filed: 2002-12-17
Abstract: A process for producing a powdered coffee comprising subjecting a liquid food to electrolysis treatment and/or current passage treatment, then spray drying or freeze drying. The liquid food may be coffee extract, concentrated coffee extract, an aqueous solution of concentrated coffee extract or an aqueous solution of instant coffee.
Patent NZ-544350-A (NZ)
Title: Trap with flush valve
Inventor: DURAND EMMA A
IPC: A01M1/02
Filed: 2004-05-12
Abstract: A flying insect trapping device is disclosed, configured to be used with a fuel supply containing combustible fuel. One aspect provides a fuel regulator for controlling fuel flow in intermittent pulses and another aspect provides a valve for enabling flushing of the combustion device.
Patent NZ-550671-A (NZ)
Title: Ozonised pharmaceutical composition and method
Inventor: STENTI DE PIRILLO HAYDEE ALBA
IPC: A61K33/00
Filed: 2005-04-20
Abstract: Disclosed is a pharmaceutical composition for use in topical application to treat diseases in human beings and animals, the composition comprising dimethylsulfoxide (DMSO), methyl sulfonyl methane, a pharmaceutical acceptable vehicle and products resulting from the ozonization of at least the vehicle.